Background: Epicutaneous sensitization to allergens is important in the pathogenesis of not only skin inflammation such as atopic dermatitis but also "atopic march" in allergic diseases such as asthma and food allergies. We here examined antibody production and skin barrier dysfunction in mice epicutaneously administered papain, a plant-derived occupational allergen belonging to the same family of cysteine proteases as mite major group 1 allergens.
INTRODUCTION
The protease activity of allergens has been implicated as an important property that endows an allergen with its allergenicity. [1] [2] [3] [4] [5] [6] [7] The protease activity of the house dust mite major group 1 allergens Der f 1 and Der p 1, two of the most important allergens common worldwide, has been shown to cause barrier dysfunction in the mucosal epithelium and skin, induce the production of pro-inflammatory cytokines in epithelial cells and keratinocytes, cleave various molecules, modulate the functions of various cell types, and induce Th2 responses. 1, 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Previous studies reported that papain, a papaya fruit-derived occupational protease allergen, stimulated epithelial cells 17 and mouse basophils in vitro 16, 18, 19 and induces Th2 re-sponses 16, [18] [19] [20] [21] and the IL-33-dependent innate 22 and adaptive 16 responses of lung eosinophilia in mice. The repeated intranasal administration of papain and recombinant Der f 1 without using adjuvants such as Alum induced allergic airway inflammation and IgE! IgG1 production in a manner dependent of the protease activity of the protease allergens in mice. 16 Skin barrier dysfunction has been reported as a major manifestation of atopic dermatitis, and its involvement in the pathogenesis has been reported. 1, 2, 23, 24 Furthermore, epicutaneous sensitization through barrier-disrupted skin has been shown to cause the "atopic march" in allergic diseases such as asthma and food allergies. 1, 23, 25, 26 We previously demonstrated that the recombinant mite major protease allergen Der f 1 9 and Staphylococcus aureus V8 protease 27 applied to the skin of mice caused skin barrier dysfunction. These results suggest that the proteases contained in allergen sources and those produced by skin-resident microbes contribute to a reduction in skin barrier function, which initiates and promotes allergen-sensitization through the skin. 1 However, whether exposure of the skin to proteases causes IgE production remains unknown. In the present study, we examined antibody production after the epicutaneous administration of proteases without using adjuvants.
METHODS

MICE
Six-to twelve-week-old female hairless mice (Skh: HR1 strain; Hoshino Laboratory Animals, Inc., Ibaraki, Japan) and C57BL! 6N mice (Japan SLC, Inc., Hamamatsu, Japan) were maintained in a specific pathogen-free animal facility at Juntendo University and used in accordance with the guidelines of the institutional committee on animal experiments.
EPICUTANEOUS ADMINISTRATION OF PAPAIN TO THE BACKS OF HAIRLESS MICE
A rectangular piece of filter paper 1 cm × 2 cm (3MM Chr, Whatmann, Middlesex, UK) was placed on the backs of hairless mice without tape stripping, and PBS (100 μl! 2 cm 2 ! site), papain (Calbiochem, San Diego, CA, USA) (50 μg! 100 μl-PBS! 2 cm 2 ! site), or S. aureus V8 protease (Pierce, Rockford, IL, USA) (5 μg! 100 μl-PBS! 2 cm 2 ! site) was perfused to the paper. Paper containing PBS, papain, or V8 protease was wrapped and immobilized with a polyurethane film (Cathereep; Nichiban, Tokyo, Japan). The direct application of PBS without the patch and occlusion were performed in other mice as a control group. Applications were repeated on days 0-6 and days 9-15.
MEASUREMENT OF TRANSEPIDERMAL WATER LOSS IN HAIRLESS MICE
Transepidermal water loss (TEWL) was measured with a Mobile Tewameter (Courage + Khazaka Electronic GmbH, Köln, Germany) on days 0 and 9 before the application and on day 16.
ELISA FOR SERUM ANTIBODY PRODUCTION IN HAIRLESS MICE
Sera were collected on days 8 and 16 to measure antibody production by ELISA. Serum total IgE was measured by a sandwich ELISA as described previously. 28, 29 Papain-specific antibodies were detected as described previously 16, 30, 31 with modifications as follows. Plates were coated with 30 μg! ml of papain, blocked with BlockAce (Snow Bland, Sapporo, Japan), and developed with HRP-conjugated antibodies specific to the murine IgG1 (rat monoclonal antibody, clone X56: BD Biosciences, San Jose, CA, USA), IgG2a (rat monoclonal antibody, clone R19-15; BD Biosciences), and IgG2b (Rabbit polyclonal antibody; Zymed, South San Francisco, CA, USA). 30, 31 Sera and detection antibodies were diluted with Solutions 1 and 2 of CanGetSignal (TOYOBO, Osaka, Japan), respectively. Serum dilutions were 1! 10000, 1! 200, and 1! 200 for detecting papain-specific IgG1, IgG2a, and IgG2b, respectively. Incubation with sera or detection antibodies to detect papain-specific IgG subclasses was for 1.5 h at room temperature. Dilutions of HRPconjugated detection antibodies were 1! 4000. The optical density (OD) at 450 nm, from which that at 570 nm was subtracted, was used as the signal for papainspecific IgGs.
TREATMENT OF PAPAIN WITH E64
Papain was treated with the irreversible inhibitor specific to cysteine proteases, E64 (Peptide Institute, Osaka, Japan), as described previously 14 with minor modifications. 16 After the treatment, free E64 was removed by dialysis. Papain, which was incubated similarly to E64-treated papain (but without the addition of E64) and dialyzed, was prepared and used for epicutaneous administration to C57BL! 6 mice. Purity and the absence of both degradation and aggregation were confirmed by electrophoresis, and protease activity was analyzed using synthetic fluorogenic substrates. 14,32
EPICUTANEOUS ADMINISTRATION OF PAPAIN TO THE EAR LOBES OF C57BL! 6 MICE
This method was originally described for sensitization to mite extract by Gao et al. 33 and we modified it for sensitization to papain as follows. Tape stripping was not performed in the present study. 12.5 μl of 10 mg! ml of papain or E64-treated papain was applied onto both sides of both ear lobes (250 μg! 25 μl! animal) on days 0, 3, 7, 10, 21, 24, and 28 for a total of 7 times.
ELISA FOR SERUM ANTIBODY PRODUCTION IN C57BL! 6 MICE
Sera were collected on days 17 and 35 to measure an- Fig. 1 Papain and S. aureus V8 protease patched on the backs of hairless mice caused skin barrier dysfunction and increased serum total IgE levels. A patch containing PBS, papain, or V8 protease with occlusion was applied to the backs of hairless mice and immobilized with a polyurethane fi lm every day on days 0-6 and days 10-15. In the control group, PBS was directly applied without the patch and occlusion (Control). TEWL was measured on days 0 and 9 before the application and day 16 (A). Sera were collected from mice in on days 8 and 16. IgE concentrations were measured by ELISA (B). *p < 0.05 signifi cantly different from Control and p < 0.05 signifi cantly different from PBS by a one-way ANOVA and Tukey post hoc test, and p < 0.05 signifi cantly different from PBS by a t-test (twotailed). Data shown are the means ± SDs for four or three mice/group and are representative of two or three independent experiments. tibody production by ELISA. Serum total IgE was measured by a sandwich ELISA as described previously. 28, 29 Papain-specific IgG antibodies were detected as described previously 16 with modifications as follows. Plates were coated with 10 μg! ml of papain and blocked with ImmunoBlock (DS Pharma Biomedical, Osaka, Japan). Sera, biotinylated anti-mouse IgE, and horseradish peroxidase (HRP)-conjugated streptavidine were diluted with PBS containing 0.05% Tween 20 and 1! 20 volume of ImmunoBlock (1! 50, 1! 250, and 1! 2500 dilutions, respectively). 16 To detect papain-specific IgE, incubations with sera, biotinylated anti-mouse IgE, and HRP-conjugated streptavidine were conducted overnight at 4°C, for 60 min at room temperature, and for 30 min at room temperature, respectively. The HRP-conjugated anti-IgG2a monoclonal antibody (clone R19-15; BD Biosciences) cross-reactive to IgG2c was used for detection of IgG2c. To detect papain-specific IgG1, IgG2c, and IgG2b, incubations with sera (1! 5000, 1! 200, and 1! 200 dilutions, respectively) and HRP-conjugated antimouse IgG subclasses were conducted for 80 min at 37°C, respectively. The OD at 450 nm, from which that at 570 nm was subtracted, was used as the signal for papain specific antibodies.
STATISTICAL ANALYSIS
A one-way analysis of variance (ANOVA) with Tukey's multiple comparison test and unpaired t-test (two-tailed) were used. Values of P < 0.05 were regarded as significant.
RESULTS
EPICUTANEOUS EXPOSURE OF THE BACKS OF HAIRLESS MICE TO PAPAIN INDUCED SKIN BARRIER DYSFUNCTION
Papain was applied in a patch to the backs of hairless mice on days 0-6 and days 9-15. TEWL was measured on days 9 and 16. The hairless phenotype of this strain simplified the experimental protocol. V8 protease, 27 a Staphylococcus aureus extracellular serine protease showing a specificity of glutamate-specific cleavage similar to S. aureus exfoliative toxins, was used as a positive control in the measurement of TEWL. In our previous report, TEWL was increased in V8 protease-patched mice on day 7 after the application on days 0-6. 27 On day 9 after the two-day interval from the application on days 0-6 (Fig. 1A , middle panel), TEWL was higher in V8 protease-patched mice than PBS-patched mice but was not in papainpatched mice. TEWL was also higher in papainpatched and V8 protease-patched mice than in mice directly administered PBS onto their backs without the patch with occlusion (Fig. 1A, Control) . TEWL was higher in papain-patched mice and V8 proteasepatched mice than in PBS-patched mice on day 16 (Fig. 1A, lower panel) , the day after the application on days 9-15. Thus, epicutaneous exposure to papain on the backs of hairless mice induced skin barrier dysfunction, although the amount of papain (50 μg! 100 μl! 2 cm 2 ! site) used to reduce barrier function was more than that of V8 protease (5 μg! 100 μl! 2 cm 2 ! site).
EPICUTANEOUS EXPOSURE OF THE BACKS OF HAIRLESS MICE TO PAPAIN UPREGULATED SERUM TOTAL IgE LEVELS AND INDUCED PAPAIN-SPECIFIC IgG PRODUCTION
Serum total IgE levels were higher in papain-patched hairless mice than in PBS-patched mice on day 8, and were also higher in V8 protease-patched mice on day 8 (Fig. 1B) . On day 8 (Fig. 2) , papain-specific IgG1 and IgG2b, but not IgG2a (Fig. 2A, C, B , respectively), were induced in papain-patched hairless mice. On day 16, higher titers of all three subclasses of papain-specific IgG examined were observed (data not shown). Thus, the epicutaneous exposure of the backs of hairless mice to papain upregulated serum total IgE levels (Fig. 1B) and induced papain-specific IgG production (Fig. 2) . V8 protease also upregulated serum total IgE levels (Fig. 1B) .
EPICUTANEOUS EXPOSURE OF THE EAR LOBES OF C57BL! 6 MICE TO PAPAIN INDUCED PAPAIN-SPECIFIC IgE AND IgG PRODUCTION IN A MANNER DEPENDENT ON THE CYSTEINE PROTEASE ACTIVITY OF PAPAIN
Recently we reported that intranasal administration of papain and recombinant Der f 1 without using adjuvants such as Alum induced allergic airway inflammation and IgE! IgG1 production in a manner dependent of the protease activity of the protease allergens in an inbred murine strain, C57BL! 6. 16 We examined the epicutaneous administration of papain in the same strain. We painted the papain solution onto the ear lobes of C57BL! 6 without tape stripping and without the patch and occlusion on days 0, 3, 7, 10, 21, 24, and 28. Although no significant difference was observed in serum total IgE on days 17 and 35 between the papain-treated and the control vehicle-treated mice of this strain (Fig. 3A) , the production of IgE and IgG subclasses specific to papain was observed (Fig. 3B,  Fig. 4, Papain) . In contrast, papain treated with E64, an irreversible inhibitor specific to cysteine proteases, did not induce significant IgE and IgG production specific to papain (Fig. 3B, 4, E64-papain) . Thus, epicutaneous exposure of the ear lobes of C57BL! 6 mice to papain induced the production of papainspecific IgE and IgG antibodies and this was dependent on the protease activity of papain. As the C57BL! 6 strain lacks the gene for IgG2a but instead express IgG2c, 34 the HRP-conjugated anti-IgG2a monoclonal antibody cross-reactive to IgG2c was used for detection of IgG2c (Fig. 4B ).
DISCUSSION
The mite-derived indoor allergens, Der f 1 and Der p 1, and plant-derived occupational allergen, papain, belong to the same family of cysteine proteases, family C1 of clan CA. 3, 35, 36 In the present study, we used papain as a model protease allergen that mimics the cysteine proteases contained in natural allergen sources such as mites and pollen. 1, 37, 38 We demonstrated that the epicutaneous administration of papain did not only disrupt skin barrier function (Fig. 1A) , but also induced IgE and IgG responses (Fig. 1B, 2-4) . Additionally, epicutaneously administered Staphylococcus aureus V8 protease also exhibited the capacity to reduce skin barrier function ( Fig. 1) and upregulate serum total IgE levels (Fig. 2) . Upregulation of total IgE levels was not observed in C57BL! 6 mice and this could be due to differences of the strains and methods of administration between the two experimental models.
The protease activity of papain markedly contributed to serum antibody production of IgE and IgG subclasses (Fig. 3B, 4) . We used the cysteine protease inhibitor, E64, which irreversibly binds to the catalytic site of papain without altering its tertiary structure. 14, 39 The inactivation of protease activity by heat denaturation has been reported to disrupt the tertiary structure and! or cause oligomerization, which are likely to affect the immunochemical properties of allergens such as antibody binding 40, 41 and the T-cell response. 14 Our results using E64-treated papain indicate that elevated serum antibody production is dependent on the cysteine protease activity of papain, but not to conformational changes or aggregation, which may cause different immune responses. Considering the serum dilution factors and ODs in ELISA for the papain-specific IgG subclasses, the epicutaneous administration of papain induced the most significant production of IgG1, the class-switch to which and IgE Th2 cytokines contribute to, among the IgG subclasses measured (Fig. 2, Fig. 4) .
To the best of our knowledge, this is the first study to report epicutaneous sensitization dependent on protease activity of the antigen, which suggests that epicutaneous exposure to environmental proteases promotes allergic sensitization. Allergen sourcederived or microbe-derived proteases, some of which are allergens (protease allergens), have been shown to cause barrier breakdown and induce innate immune responses in various cell types. 1, [3] [4] [5] [6] [7] The mouse models described here should be prototype models, which will be useful for analyzing the natural history of allergic diseases initiated with epicutaneous sensitization to proteases. We are now conducting further analyses using these models to explore the mechanisms of the protease-dependent epicutaneous sensitization and its roles in allergic diseases.
